Clinical Trial Update: Safety and Performance of the Automated Fluid Shunt in Patients With Ascites and Diuretic Resistance [Phase 2, Phase 3]

View source ↗

Summary

The study completed Phase 2 and Phase 3 evaluating the safety and performance of the Automated Fluid Shunt for patients with ascites and diuretic resistance.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ascites

Drugs mentioned

• Automated Fluid Shunt

Snippet

Sponsor: NovaShunt AG | Conditions: Ascites | Phase 2, Phase 3 | Status: COMPLETED